UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000028920
Receipt number R000033065
Scientific Title Evaluation of peripheral retinal abnormalities in branch retinal vein occlusion - a relationship with the visual prognosis -
Date of disclosure of the study information 2017/10/01
Last modified on 2017/08/31 15:29:36

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Evaluation of peripheral retinal
abnormalities in branch retinal vein
occlusion - a relationship with the
visual prognosis -

Acronym

Peripheral retinal abnormalities and
visual prognosis in branch retinal vein
occlusion

Scientific Title

Evaluation of peripheral retinal
abnormalities in branch retinal vein
occlusion - a relationship with the
visual prognosis -

Scientific Title:Acronym

Peripheral retinal abnormalities and
visual prognosis in branch retinal vein
occlusion

Region

Japan


Condition

Condition

Retinal Vein Occlusion

Classification by specialty

Ophthalmology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To examine the relationship between
visual prognosis and the location of
retinal abnormal findings detected by a
wide-field fluorescein angiography as
well as retinal photocoagulation (PHC)
for the peripheral nonperfused area in
patients with branch retinal vein
occlusion.

Basic objectives2

Others

Basic objectives -Others

Confirmatory

Trial characteristics_1

Confirmatory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

presence of microaneurysm, retinal
hyperpermeability, and neovascularization

Key secondary outcomes

best-corrected visual acuity, central
retinal thickness


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1.RVO eyes with nonperfused areas
2.Japanese patients
3.Patients considered as eligible for
study by the investigator

Key exclusion criteria

1.Patients whose images were too poor
quality to be analyzed, who had thick
retinal hemorrhage or severe macular edema
2.Presence of other macular diseases
3.High myopia -6.0 diopter(D)or worse
4.Patients judged by the investigator to
be ineligible for other reasons

Target sample size

40


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yoshio Hirano

Organization

Nagoya City University Graduate School of Medical Sciences

Division name

Department of Ophthalmology and Visual Science

Zip code


Address

1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya 467-8601, Japan

TEL

052-853-8251

Email

yoshio.hirano@gmail.com


Public contact

Name of contact person

1st name
Middle name
Last name Yoshio Hirano

Organization

Nagoya City University Graduate School of Medical Sciences

Division name

Department of Ophthalmology and Visual Science

Zip code


Address

1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya 467-8601, Japan

TEL

052-853-8251

Homepage URL


Email

yoshio.hirano@gmail.com


Sponsor or person

Institute

Department of Ophthalmology and Visual Science, Nagoya City University Graduate School of Medical Sciences

Institute

Department

Personal name



Funding Source

Organization

Department of Ophthalmology and Visual Science, Nagoya City University Graduate School of Medical Sciences

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 10 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results

The presence rates of microaneurysms,
vascular hyperpermeability,
retinal neovascularization in the
peripheral retina were significantly lower than in other areas. The presence of the retinal peripheral abnormalities or PHC for the retinal nonperfused area did not necessarily affect the visual prognosis and persistent macular edema.

Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2017 Year 02 Month 01 Day

Date of IRB


Anticipated trial start date

2017 Year 03 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

There was no association between the PHC
application and vitreous hemorrhage.


Management information

Registered date

2017 Year 08 Month 30 Day

Last modified on

2017 Year 08 Month 31 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000033065


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name